SEPN — Septerna, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1984086 ·
Last close
$34.45
Market Cap
$1.55B
52W High
$38.04
52W Low
$23.15
ADV30
479,903
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 26,523,000 | — | -13,300,000 | -8,637,000 | 569,688,000 | 71,605,000 | 191,230,000 |
| Dec 2025 | 24,118,000 | — | -16,023,000 | -10,738,000 | 596,187,000 | 120,722,000 | 214,261,000 |
| Sep 2025 | 21,495,000 | — | -9,886,000 | 8,173,000 | 606,653,000 | 319,989,000 | 217,922,000 |
| Jun 2025 | 119,000 | — | -28,978,000 | -24,838,000 | 415,231,000 | 189,311,000 | 37,674,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$107,899,000
Investing CF
$-248,295,000
Financing CF
$1,956,000
CapEx
$-968,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.81
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-175,890,000
Inventory
—
Receivables
$14,290,000
ST Investments
$275,796,000
EBIT TTM
$-68,187,000
Pretax Income TTM
$-35,691,000
Interest Exp TTM
—
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$72,255,000
EBITDA
$-66,559,000
Free Cash Flow
$24,014,124
Enterprise Value
$1,261,446,272
Total Cash
$347,400,992
Total Debt
$23,090,000
Shares Out
45,075,533
Trailing EPS
$-0.80
Book Value
$8.43
ROE
-9.3%
ROA
-8.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 45,951,000 | -80,797,000 | -48,879,000 | 596,187,000 | 214,261,000 | — | 110,189,000 |
| Dec 2024 | 1,075,000 | -80,823,000 | -71,798,000 | 456,554,000 | 36,507,000 | — | -67,470,000 |
| Dec 2023 | 151,000 | -45,550,000 | 4,180,000 | 130,867,000 | 169,241,000 | — | -38,723,000 |
| Dec 2022 | 0 | -27,967,000 | -27,676,000 | 36,119,000 | 80,320,000 | — | -23,303,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-2.66
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| INVA | Innoviva, Inc. | $1.55B | $20.97 | — |
| MLTX | MoonLake Immunotherapeutics | $1.57B | $18.44 | — |
| SRPT | Sarepta Therapeutics, Inc. | $1.57B | $14.86 | — |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.54B | $44.04 | — |
| FBRX | Forte Biosciences, Inc. | $1.57B | $76.60 | — |
News headlines (Yahoo Finance, 1h cache)
Septerna's Chief People Officer Sold Nearly 12,000 Company Shares. What Does That Mean for Investors?
2026-07-05 13:55 · Yahoo
Is Septerna, Inc. (SEPN) Stock a Biotech Opportunity With a Potential First-in-Class Hypoparathyroidism Treatment?
2026-07-02 19:58 · Yahoo
Is Septerna a Stock to Sell After an Insider Let Go of 15,000 Shares?
2026-06-30 03:25 · Yahoo
Protego Biopharma Appoints Jae B. Kim, MD, as Chief Medical Officer
2026-06-08 11:00 · Yahoo
Party Time: Brokers Just Made Major Increases To Their Septerna, Inc. (NASDAQ:SEPN) Earnings Forecasts
2026-05-17 14:47 · Yahoo
Earnings Update: Septerna, Inc. (NASDAQ:SEPN) Just Reported And Analysts Are Boosting Their Estimates
2026-05-15 14:08 · Yahoo
Septerna, Inc. (SEPN) Reports Q1 Loss, Tops Revenue Estimates
2026-05-11 21:25 · Yahoo
Septerna Highlights Business Progress and Reports First Quarter 2026 Financial Results
2026-05-11 20:01 · Yahoo
Liquidia Corporation (LQDA) Surpasses Q1 Earnings and Revenue Estimates
2026-05-11 11:45 · Yahoo
How Analyst Upgrade and Conference Spotlight Will Impact Septerna (SEPN) Investors
2026-05-08 13:19 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.